|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.1110 - 0.1139|
|52 Week Range||0.0088 - 0.1973|
|Beta (5Y Monthly)||1.90|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
Nicholas Sosiak, Chief Financial Officer, Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) and his team joined Berk Sumen, Head, Company Services, TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and close the market.
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade indoor cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced its common shares will be listed on the TSX Venture Exchange (the "TSXV"). The common shares of the Company will commence trading on TSXV at the opening on Thursday, April 8, 2021. The Company is presently trading on the Canadian Stock Exchange ("CSE"). At the commencement of trading on the TSXV, the securities of the Company will be delisted from the CSE with no resulting change to the Company's ticker (LOVE).